These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 15556626

  • 1. Vitamin D3 inhibits fatty acid synthase expression by stimulating the expression of long-chain fatty-acid-CoA ligase 3 in prostate cancer cells.
    Qiao S, Tuohimaa P.
    FEBS Lett; 2004 Nov 19; 577(3):451-4. PubMed ID: 15556626
    [Abstract] [Full Text] [Related]

  • 2. The role of long-chain fatty-acid-CoA ligase 3 in vitamin D3 and androgen control of prostate cancer LNCaP cell growth.
    Qiao S, Tuohimaa P.
    Biochem Biophys Res Commun; 2004 Jun 25; 319(2):358-68. PubMed ID: 15178414
    [Abstract] [Full Text] [Related]

  • 3. Expression and vitamin D3 regulation of long-chain fatty-acid-CoA ligase 3 in human prostate cancer cells.
    Qiao S, Tuohimaa P.
    Prostaglandins Leukot Essent Fatty Acids; 2011 Jun 25; 84(1-2):19-23. PubMed ID: 21041072
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of fatty acid synthase expression by 1alpha,25-dihydroxyvitamin D3 in prostate cancer cells.
    Qiao S, Pennanen P, Nazarova N, Lou YR, Tuohimaa P.
    J Steroid Biochem Mol Biol; 2003 May 25; 85(1):1-8. PubMed ID: 12798352
    [Abstract] [Full Text] [Related]

  • 5. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
    Koike M, Koshizuka K, Kawabata H, Yang R, Taub HE, Said J, Uskokovic M, Tsuruoka N, Koeffler HP.
    Anticancer Res; 1999 May 25; 19(3A):1689-97. PubMed ID: 10470102
    [Abstract] [Full Text] [Related]

  • 6. Overexpression and hyperactivity of breast cancer-associated fatty acid synthase (oncogenic antigen-519) is insensitive to normal arachidonic fatty acid-induced suppression in lipogenic tissues but it is selectively inhibited by tumoricidal alpha-linolenic and gamma-linolenic fatty acids: a novel mechanism by which dietary fat can alter mammary tumorigenesis.
    Menendez JA, Ropero S, Mehmi I, Atlas E, Colomer R, Lupu R.
    Int J Oncol; 2004 Jun 25; 24(6):1369-83. PubMed ID: 15138577
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. 25-Hydroxyvitamin D3, the prohormone of 1,25-dihydroxyvitamin D3, inhibits the proliferation of primary prostatic epithelial cells.
    Barreto AM, Schwartz GG, Woodruff R, Cramer SD.
    Cancer Epidemiol Biomarkers Prev; 2000 Mar 25; 9(3):265-70. PubMed ID: 10750664
    [Abstract] [Full Text] [Related]

  • 12. Increased fatty acid synthase expression and activity during progression of prostate cancer in the TRAMP model.
    Pflug BR, Pecher SM, Brink AW, Nelson JB, Foster BA.
    Prostate; 2003 Nov 01; 57(3):245-54. PubMed ID: 14518031
    [Abstract] [Full Text] [Related]

  • 13. CCAAT/enhancer-binding protein delta: a molecular target of 1,25-dihydroxyvitamin D3 in androgen-responsive prostate cancer LNCaP cells.
    Ikezoe T, Gery S, Yin D, O'Kelly J, Binderup L, Lemp N, Taguchi H, Koeffler HP.
    Cancer Res; 2005 Jun 01; 65(11):4762-8. PubMed ID: 15930295
    [Abstract] [Full Text] [Related]

  • 14. Epigallocatechin-3-gallate is a potent natural inhibitor of fatty acid synthase in intact cells and selectively induces apoptosis in prostate cancer cells.
    Brusselmans K, De Schrijver E, Heyns W, Verhoeven G, Swinnen JV.
    Int J Cancer; 2003 Oct 10; 106(6):856-62. PubMed ID: 12918062
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA, Mehmi I, Atlas E, Colomer R, Lupu R.
    Int J Oncol; 2004 Mar 10; 24(3):591-608. PubMed ID: 14767544
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Characterization of triacsin C inhibition of short-, medium-, and long-chain fatty acid: CoA ligases of human liver.
    Vessey DA, Kelley M, Warren RS.
    J Biochem Mol Toxicol; 2004 Mar 10; 18(2):100-6. PubMed ID: 15122652
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.